Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Luis H. Alejo"'
Autor:
Svetlana E. Semina, Luis H. Alejo, Shivani Chopra, Nidhi S. Kansara, Irida Kastrati, Carol A. Sartorius, Jonna Frasor
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-19 (2022)
Abstract Background Up to 40% of patients with estrogen receptor-positive (ER+) breast cancer experience relapse. This can be attributed to breast cancer stem cells (BCSCs), which are known to be involved in therapy resistance, relapse, and metastasi
Externí odkaz:
https://doaj.org/article/f3161eb0e67345e59d5aa35198f1b009
Autor:
Jonna Frasor, Wilbert Zwart, Sabine C. Linn, Geoffrey L. Greene, Elaine T. Alarid, Marleen Kok, Hugo M. Horlings, Joshua D. Stender, Svitlana D. Brovkovych, Luis H. Alejo, Svetlana E. Semina, Stacey E. P. Joosten, Irida Kastrati
Supplemental Figure 1. Tamoxifen treatment induces expression of NFκBB-related genes. Supplementary Figure 2. Immune cell composition and numbers in the tumor microenvironment do not significantly change upon tamoxifen treatment. Supplementary Figur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0039c4867336c4e21797615e8c21b830
https://doi.org/10.1158/1541-7786.22517821
https://doi.org/10.1158/1541-7786.22517821
Autor:
Jonna Frasor, Wilbert Zwart, Sabine C. Linn, Geoffrey L. Greene, Elaine T. Alarid, Marleen Kok, Hugo M. Horlings, Joshua D. Stender, Svitlana D. Brovkovych, Luis H. Alejo, Svetlana E. Semina, Stacey E. P. Joosten, Irida Kastrati
Supplemental Table 3. GSEA enrichment plots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd6e87afccf94de96a3300f77efba1c
https://doi.org/10.1158/1541-7786.22517824.v1
https://doi.org/10.1158/1541-7786.22517824.v1
Autor:
Jonna Frasor, Wilbert Zwart, Sabine C. Linn, Geoffrey L. Greene, Elaine T. Alarid, Marleen Kok, Hugo M. Horlings, Joshua D. Stender, Svitlana D. Brovkovych, Luis H. Alejo, Svetlana E. Semina, Stacey E. P. Joosten, Irida Kastrati
Supplemental Table 2. DE Genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0ff584cec9677b32ba3d9d7d689165
https://doi.org/10.1158/1541-7786.22517827
https://doi.org/10.1158/1541-7786.22517827
Autor:
Jonna Frasor, Wilbert Zwart, Sabine C. Linn, Geoffrey L. Greene, Elaine T. Alarid, Marleen Kok, Hugo M. Horlings, Joshua D. Stender, Svitlana D. Brovkovych, Luis H. Alejo, Svetlana E. Semina, Stacey E. P. Joosten, Irida Kastrati
Supplemental Table 1. Patient characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5735c9f6f1ae5b7ac1c16ac7670f86f2
https://doi.org/10.1158/1541-7786.22517830
https://doi.org/10.1158/1541-7786.22517830
Autor:
Jonna Frasor, Wilbert Zwart, Sabine C. Linn, Geoffrey L. Greene, Elaine T. Alarid, Marleen Kok, Hugo M. Horlings, Joshua D. Stender, Svitlana D. Brovkovych, Luis H. Alejo, Svetlana E. Semina, Stacey E. P. Joosten, Irida Kastrati
Supplemental Materials and Methods and Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212580fc1d86d3e57783d811a2e882eb
https://doi.org/10.1158/1541-7786.22517833
https://doi.org/10.1158/1541-7786.22517833
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2848
Most metastatic breast cancers arise from estrogen receptor α (ER)-positive disease, and yet the role of ER in promoting metastasis is unclear. Here, we used an ER+ breast cancer cell line that is highly invasive in an ER- and IKKβ-dependent manner
Autor:
Hugo M. Horlings, Marleen Kok, Stacey E. P. Joosten, Jonna Frasor, Irida Kastrati, Svitlana D. Brovkovych, Svetlana E. Semina, Luis H. Alejo, Joshua D. Stender, Geoffrey L. Greene, Sabine C. Linn, Wilbert Zwart, Elaine T. Alarid
Publikováno v:
Mol Cancer Res
The purpose of this study was to identify critical pathways promoting survival of tamoxifen-tolerant, estrogen receptor α positive (ER+) breast cancer cells, which contribute to therapy resistance and disease recurrence. Gene expression profiling an
Publikováno v:
Horm Cancer
There is a desperate need in the field for mouse mammary tumors and cell lines that faithfully mimic estrogen receptor (ER) expression and activity found in human breast cancers. We found that several mouse mammary cancer cell lines express ER but fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::988a1642904a8205bed7eb51d93fc639
https://europepmc.org/articles/PMC7386283/
https://europepmc.org/articles/PMC7386283/